Item 2.02 Results of Operations and Financial Condition.




As of December 31, 2021, Tricida, Inc., (the "Company") had cash, cash
equivalents and investments of approximately $150.6 million (unaudited).
Because the Company's consolidated financial statements for the year ended
December 31, 2021 have not yet been finalized or audited, the preliminary
statement of the Company's cash, cash equivalents and investments as of December
31, 2021 in this Item 2.02 is subject to change, and the Company's actual cash,
cash equivalents and investments as of December 31, 2021 may differ materially
from this preliminary estimate. Accordingly, you should not place undue reliance
on this preliminary estimate.
Item 7.01   Regulation FD Disclosure.


On January 10, 2022, the Company intends to make a prerecorded presentation at
the H.C. Wainwright BIOCONNECT Virtual Conference that provides a Company
overview, business update and progress on the Company's key initiatives.
On January 13, 2022, the Company intends to make a presentation at the 40th
Annual J.P. Morgan Healthcare Conference that provides a Company overview,
business update and progress on the Company's key initiatives. A form of the
Company's slide presentation to be used at the H.C. Wainwright BIOCONNECT
Virtual Conference and the J.P Morgan Healthcare Conference is being furnished
as Exhibit 99.1 to this Current Report on Form 8-K, and a copy is available on
the Company's website at IR.Tricida.com.
The information contained in Item 2.02 and Item 7.01 of this Current Report on
Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and Item
7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, or the Securities
Exchange Act of 1934, as amended, except as expressly stated by specific
reference in such filing.
Item 9.01   Financial Statements and Exhibits.


(d) Exhibits.
Exhibit Number              Description

99.1                          Company Presentation

104                         Cover Page Interactive Data File (embedded

within the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses